Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Metacrine and Equillium Mutually Agree to Terminate Definitive Merger Agreement

Metacrine, Inc. (NASDAQ:MTCR) and Equillium, Inc. today announced the mutual termination of their previously announced definitive merger agreement. Metacrine is continuing to evaluate all strategic opportunities.  
byBenzinga Newsdesk
December 23, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Metacrine, Inc. (NASDAQ:MTCR) and Equillium, Inc. today announced the mutual termination of their previously announced definitive merger agreement. Metacrine is continuing to evaluate all strategic opportunities.
 

Additional information regarding the termination of the definitive merger agreement is provided set forth in a Current Report on Form 8-K filed by Metacrine with the U.S. Securities and Exchange Commission today and is available at www.sec.gov and on Metacrine’s website under the heading “Investors.”

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Nike’s Successful Air Max DN Launch Gets Off On The Right Foot, Says Analyst

By Shivani Kumaresan
March 27, 1:46 PM
Wedbush's Tom Nikic reaffirms an Outperform rating for Nike Inc (NYSE:NKE), foreseeing positive outcomes from the recent "Air Max Day" celebration. With the successful debut of the new Air Max DN model, which quickly sold out on Nike.com, Nikic highlights the significance of this release in reviving Nike's product development prowess amidst recent stagnation.

NKE